We know we are not the only ones who want to see innovative treatments transform lives. Partnerships with other companies and advocacy organizations that share our mission help us impact more people.
FIRST was established to help individuals and families affected by ichthyosis. The organization educates, inspires, and connects families and individuals affected by Ichthyosis and related skin types. Services include biennial national family conferences, regional meetings, a regional support network, publications, advocacy and a research program.
Quoin has in-licensed a bi-functional biologic from QUT for the treatment of Netherton Syndrome.
Quoin has entered into a licensing and distribution agreement with GenPharm for the Middle East.
AFT is Quoin’s licensing and distribution partner for Australia and New Zealand.
Quoin Pharmaceuticals is an emerging specialty pharmaceutical company dedicated to supporting underserved patients, their families, communities, and care teams around the world.